(Q37449679)

English

Pharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis

scientific article published on 05 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

7 references

23 March 2019

22 June 2019

22 October 2019

4 November 2019

7 November 2019

28 May 2020

29 May 2020

Pharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

trypanosomiasis

0 references

African trypanosomiasis

7 references

23 March 2019

22 June 2019

22 October 2019

4 November 2019

7 November 2019

28 May 2020

29 May 2020

1 reference

22 October 2019

inorganic compound

1 reference

4 November 2019

1 reference

7 November 2019

carboxylic acid

1 reference

7 November 2019

1 reference

7 November 2019

Trypanosoma brucei rhodesiense

2 references

28 May 2020

29 May 2020

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Stephen Wring

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Eric Gaukel

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Bakela Nare

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Robert Jacobs

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Beth Beaudet

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Tana Bowling

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Luke Mercer

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Cyrus Bacchi

8

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Nigel Yarlett

9

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Ryan Randolph

10

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Robin Parham

11

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Cindy Rewerts

12

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Jacob Platner

13

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Robert Don

14

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

5 September 2013

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1 January 2014

7 references

23 March 2019

22 June 2019

22 October 2019

4 November 2019

7 November 2019

28 May 2020

29 May 2020

8 references

Europe PubMed Central

PMC publication ID

20 August 2017

23 March 2019

22 June 2019

22 October 2019

4 November 2019

7 November 2019

28 May 2020

29 May 2020

141

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

104-118

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

copyright license

Creative Commons Attribution

7 references

23 March 2019

22 June 2019

22 October 2019

4 November 2019

7 November 2019

28 May 2020

29 May 2020

copyright status

0 references

on focus list of Wikimedia project

0 references

Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

23 August 2017

SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

23 August 2017

Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

23 August 2017

Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

23 August 2017

Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

23 August 2017

CSF as a surrogate for assessing CNS exposure: an industrial perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

23 August 2017

Migration of African trypanosomes across the blood-brain barrier.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

23 August 2017

Drugs and drug resistance in African trypanosomiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

23 August 2017

A direct method for measuring mouse capillary cortical blood volume using multiphoton laser scanning microscopy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

23 August 2017

Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: importance of persistence of caspofungin in tissues to understanding drug activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

23 August 2017

Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

23 August 2017

Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

23 August 2017

Ion suppression in mass spectrometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

23 August 2017

In vitro prediction of brain penetration - a case for free thinking?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

23 August 2017

Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

6 September 2017

Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

6 September 2017

Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

6 September 2017

Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

6 September 2017

Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

6 September 2017

Pharmacokinetics of melarsoprol in uninfected vervet monkeys

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

6 September 2017

African trypanosome interactions with an in vitro model of the human blood-brain barrier

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

14 September 2017

In vitro absorption and secretory quotients: practical criteria derived from a study of 331 compounds to assess for the impact of P-glycoprotein-mediated efflux on drug candidates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

14 September 2017

The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

26 June 2018

Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

26 June 2018

Rational use of in vitro P-glycoprotein assays in drug discovery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

26 June 2018

Improved measurement of drug exposure in the brain using drug-specific correction for residual blood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

2 September 2018

Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

2 September 2018

Receptor occupancy and brain free fraction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

2 September 2018

Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

2 September 2018

In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

2 September 2018

Comparison of the in vitro drug sensitivity of Trypanosoma brucei gambiense strains from West and Central Africa isolated in the periods 1960-1995 and 1999-2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

2 September 2018

Steady-state brain concentrations of antihistamines in rats: interplay of membrane permeability, P-glycoprotein efflux and plasma protein binding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

2 September 2018

Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

2 September 2018

Relapsed parasitaemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

2 September 2018

Outbreak news. Avian influenza--spread of the virus to new countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

2 October 2018

Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3884839

3 December 2018

Density, fat, water and solids in freshly isolated tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/24007596

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium

1 reference

https://pubmed.ncbi.nlm.nih.gov/24007596

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating and tissue hematocrits of normal unanesthetized mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/24007596

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1017/S003118201300098X

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37449679&oldid=2169687802"